Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2011 Apr 19;154(8):563-5.
doi: 10.7326/0003-4819-154-8-201104190-00009.

If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era

Jason V Baker, Keith Henry
Editorial

If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era

Jason V Baker et al. Ann Intern Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cumulative HIV-related Disease Risk by CD4 Count
A schematic interpretation of the benefits of ART to reduce individual health risk based on the CD4+ count. Causes of morbidity and mortality are delineated between AIDS and non-AIDS-related causes. Initiating ART at higher versus lower CD4 thresholds may result in a much smaller absolute benefit as indicated by the slope of curve. The strategy to move ART initiation earlier and at higher CD4+ counts with the ultimate goal of identifying and treating everyone will, at some point, outpace available resources.
See this image and copyright information in PMC

Comment on

References

    1. Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Department of Health and Human Services. MMWR. 1998;47(RR-5):1–83. - PubMed
    1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. [Accessed February 2011];Department of Health and Human Services. 2011 Jan;:1–166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf.
    1. The HIV-CAUSAL Collaboration. When to initiate combined antiretroviral therapy to reduce rates of mortality and AIDS-defining illness in HIV-infected individuals in developed countries. Ann Intern Med. 2011 in press. - PMC - PubMed
    1. When To Start Consortium. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet. 2009;373(9672):1352–1363. - PMC - PubMed
    1. Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med. 2009;360(18):1815–1826. - PMC - PubMed

MeSH terms

Substances